Cardioplegic (Baxter Healthcare Corporation)


Welcome to the PulseAid listing for the Cardioplegic drug offered from Baxter Healthcare Corporation. This Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Baxter Healthcare Corporation
NON-PROPRIETARY NAME: Calcium Chloride, Magnesium Chloride, Potassium Chloride and Sodium Chloride
SUBSTANCE NAME: CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA]
ROUTE: INTRA-ARTERIAL
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2000-04-21
END MARKETING DATE: 0000-00-00


Cardioplegic HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCardioplegic from Baxter Healthcare Corporation
LABELER NAME: Baxter Healthcare Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 17.6; 325.3; 119.3; 643(mg/100mL; mg/100mL; mg/100mL; mg/100mL)
START MARKETING DATE: 2000-04-21
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0338-0341_32d27009-8568-4468-b8cc-7be67d27d783
PRODUCT NDC: 0338-0341
APPLICATION NUMBER: ANDA075323

Other CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Baxter Healthcare CorporationCardioplegic